ProCE Banner Activity

CE / CME

Integrating the Latest HIV Treatment Safety and Tolerability Data Into Clinical Practice

Text Module
In this case-based, focused activity, review the latest data from 2020 scientific meetings on weight gain, cardiometabolic endpoints, and pregnancy outcomes with current ART regimens.

Pharmacists : 1.00 contact {hour} ({0.1} CEUs)

Physicians : maximum of 1.00 AMA PRA Category 1 {Credit}

Registered Nurses: 1.00 Nursing contact {hour}

Released: August 11, 2020

Expiration: August 10, 2021

No longer available for credit.

Share

Faculty

Kassem Bourgi

Kassem Bourgi, MD

Assistant Professor of Medicine
Division of Infectious Disease
Department of Internal Medicine
Indiana University 
Eskenazi Health & Indiana University Health
Indianapolis, Indiana

Provided by

Provided by the USF Health
ProCE Banner

Supporters

Supported by an educational grant from

Janssen Therapeutics Division of Janssen Products

Learning Objectives

Upon completion of this activity, participants should be able to:
  • Select among recommended first-line regimens for individual patients, considering risk factors for reduced safety or tolerability with specific treatment options
  • Provide optimal care for women with HIV, including during pregnancy, integrating data on safety and tolerability alongside other important factors

Faculty Disclosure

Primary Author

Kassem Bourgi, MD

Assistant Professor of Medicine
Division of Infectious Disease
Department of Internal Medicine
Indiana University 
Eskenazi Health & Indiana University Health
Indianapolis, Indiana

Kassem Bourgi, MD, has disclosed that he has received funds for research support from Gilead Sciences.

Staff Disclosure

Staff

Megan Cartwright, PhD

Senior Clinical Editor

Megan Cartwright, PhD, has no relevant conflicts of interest to report.

Petra Cravens, PhD

Editorial Contributor

Petra Cravens, PhD, has no relevant conflicts of interest to report.

Edward King, M.A.

Vice President, Editorial
Clinical Care Options, LLC

Edward King, MA, has no relevant conflicts of interest to report.

Carolyn Skowronski, PharmD

Associate Director, Scientific Services

Carolyn Skowronski, PharmD, has no relevant conflicts of interest to report.

Julie Skowronski, FNP-BC

Julie Skowronski, FNP-BC, has no relevant conflicts of interest to report.

Instructions for Credit

USF Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. 

Credit Designation

USF Health designates this enduring material for a maximum of 1.0 AMA PRA Category 1 CreditTM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

USF Health is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

A maximum of 1.0 contact hour may be earned by learners who successfully complete this continuing nursing education activity.

USF Health is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This knowledge-based program has been approved for 1.0 contact hour (0.01 CEU). Universal program number is as follows: 0230-9999-20-022-H02-P

Type of activity: Knowledge

For Pharmacists:
It is the responsibility of the pharmacy participant to ensure the provider has the learner’s birthday and e-Profile ID (ePID)/NABP number; it is the responsibility of the provider to submit to CPE Monitor participant information within 60 days of the activity for all participants who have attended, attested to their participation, and provided their ePID/NABP number and birthdate. 

ACPE indicates it is the responsibility of the pharmacy professional to confirm the status of their NABP contact hours before 60 days past the activity. If there are any discrepancies, contact the provider immediately. You may contact USF Health through cpdsupport@usf.edu.

Additional Information

Participation in this self-study activity should be completed in approximately 1 hours. To successfully complete this activity and receive credit, participants must follow these steps during the period from August 11, 2020, through August 10, 2021:

1. Register online at http://www.clinicaloptions.com.
2. Read the target audience, learning objectives, and faculty disclosures.
3. Study the educational activity online or printed out.
4. Submit answers to the posttest questions and evaluation questions online.

You must receive a test score of at least 50% and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the posttest confirmation page. Records of all CME/CE activities completed can be found on the "CME/CE Manager" page. There are no costs/fees for this activity.

Program Medium

This program has been made available online.


Goal


The goal of this activity is to improve learners’ competence in applying the latest safety and tolerability data when individualizing ART regimen selection and management for patients with HIV infection.